Biopharma News : Biopharma and Pharma news from all around the world :
- Pipeline Therapeutics Appoints Julie Iwashita as Vice President of Clinical Operations
- North America Automated Dispensing Systems Market Forecast to 2027 Featuring Cerner Corporation, Capsa Healthcare, OMNICELL., ARxIUM, and Accu-Chart Plus Healthcare Systems – ResearchAndMarkets.com
- Europe Cancer Vaccines Market Forecast to 2027 with COVID-19 Impact Insights – ResearchAndMarkets.com
- Discovery Life Sciences and Scientist.com Partner to Advance Liquid Biopsy Development and Immunotherapy Research
- Global Precision Medicines Market Insights to 2028 – Impact of COVID-19 – ResearchAndMarkets.com
- Hy-Vee Launches New Pharmacy Benefits Manager Subsidiary
- ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal Encephalopathy
- Karuna Therapeutics Appoints David Wheadon, M.D., to Its Board of Directors
- Multiple Myeloma Research Foundation and Dana-Farber Cancer Institute Announce Groundbreaking Collaboration to Advance Progress for Smoldering Multiple Myeloma Patients
- Octapharma USA Presents Research on Congenital & Acquired Bleeding Disorders at ASH Annual Meeting
- Know Labs Provides Update on Company Business, Impact of Covid-19
- Horizon Therapeutics plc Provides $1 Million in Scholarships to Help Economically Disadvantaged Students and Students of Color Further Their Liberal Arts and Health Professions Education
- Neuboron Medtech, a BNCT Total Solution Provider, Enters Joint-Venture Agreement With TAE Life Sciences, Further Consolidating Neuboron’s Global Influence
- Insights on the Mycoplasma Testing Market 2020-2024: COVID-19 Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2024 – Technavio
- Shape Therapeutics Unveils AAVid™ Capsid Discovery Platform and Identification of Novel Tissue-Specific AAV Variants, Solving a Fundamental Delivery Challenge in Gene Therapy
- UroGen Pharma Announces Podium Presentation of Final Jelmyto® Data From Pivotal OLYMPUS Trial at the Annual Meeting of the Society of Urologic Oncology
- Qpex Biopharma Initiates Phase 1 Clinical Trial of QPX7728 for Drug-Resistant Bacterial Infections
- Sema4 Opens its Second State-of-the-Art Clinical Laboratory in Connecticut; Will Be Home to 300+ Employees
- Alnylam Completes Enrollment in ILLUMINATE-C Phase 3 Study of Lumasiran, an RNAi Therapeutic, for the Treatment of Advanced Primary Hyperoxaluria Type 1
- Janssen Submits Application to U.S. FDA Seeking Approval of Amivantamab for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
- Taysha Gene Therapies Receives Rare Pediatric Disease and Orphan Drug Designations for TSHA-103 for the Treatment of Epilepsy Caused by SLC6A1 Haploinsufficiency
- Eyenovia Announces FDA Acceptance of IND for MicroLine for Presbyopia, Clearing Path to Initiate Phase 3 VISION Trial by Year End
- PureTech Initiates Phase 2 trial of LYT-100 (Deupirfenidone) in Long COVID Respiratory Complications and Related Sequelae
- Greenwich LifeSciences Announces New Manufacturing Agreement for its Planned Phase III Clinical Trial and Enters into Lease for Office and Lab Space
- Neurogene Announces EMA Grants Orphan Drug Designation for Aspartylglucosaminuria Gene Therapy
- Vizient Announces Novaplus Enhanced Supply Agreement with Pfizer for 7 Additional Essential Medications
- LivaNova and Gyrus Capital Enter into Agreement for the Purchase of Heart Valve Business
- Memo Therapeutics AG’s Antibody Against SARS-CoV-2 Demonstrates Potent Therapeutic and Prophylactic Activity in Advanced COVID-19 Disease Model
- Insights on the Global Stem Cell Therapy Market 2020-2024: COVID-19 Analysis, Drivers, Restraints, Opportunities, and Threats – Technavio
- Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development
Biotech – Biopharma News!
- BodySmart Finance Limited: Coupon Payment Announcement
- Xlife Sciences AG: Xlife Sciences expands its project portfolio
- MorphoSys’ Licensee Announces Approval by the European Commission for Tremfya(R) (guselkumab) for Treatment of Adults with Active Psoriatic Arthritis (PsA)
- Efficacy Data from Adrenomed’s AdrenOSS-2 Phase II trial evaluating Adrecizumab (HAM8101) in Septic Shock presented at DIVI
- Thomas Biegi Joins MorphoSys as Head of Corporate Communications
- DR. JUERGEN BECK WILL LEAVE THE PAION AG MANAGEMENT BOARD ON 31 DECEMBER 2020 AS PLANNED
- Medartis announces strategic partnership with KeriMedical
- Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis
- M1 Kliniken AG: Mr. Patrick Brenske joins the board of HAEMATO AG. Promotion of the product business as core task of the integration of the Haemato Group into the M1 Kliniken AG – Group
- HAEMATO AG: Expansion of the board of directors: Strengthening the strategic and operative implementa-tion of the product business in the Haemato Group
- Adrenomed closes EUR 22 million equity financing to accelerate development of Adrecizumab (HAM8101) and provides business update
- PharmaSGP publishes Q3 Interim Statement 2020
- Vivoryon Therapeutics N.V.: Vivoryon Therapeutics AG Announces Conversion into Vivoryon Therapeutics N.V.
- PharmaSGP Holding SE: Adjustment of full-year forecast 2020 due to expected weaker fourth quarter following COVID-19-related restrictions
- MPH Health Care AG: Preliminary IFRS third quarter 2020 results published. Equity (net asset value) amounts to € 194.39 million. This corresponds to € 45.40 per share.
- Medios AG: Sales increase to more than €1 billion through acquisition of Cranach Pharma GmbH
- Medios AG: Sales increase to more than €1 billion through acquisition of Cranach Pharma GmbH
- Medios AG acquires Cranach Pharma GmbH; issue of 4,180,000 new Medios shares; significant increase in sales expected in 2021 to over €1 billion
- Medios AG acquires Cranach Pharma GmbH; issue of 4,180,000 new Medios shares; significant increase in sales expected in 2021 to over €1 billion
- Asklepios Kliniken: Consolidated net operating income impacted by continuing coronavirus pandemic
- STRATEC SE APPOINTS NEW SUPERVISORY BOARD CHAIR
- New branding for a new vision: DocMorris
- Biotest AG: Biotests Pentaglobin(R) is a treatment option for COVID-19 patients additionally affected by bacterial infections
- Vivoryon Therapeutics AG: Vivoryon Therapeutics Reports Third Quarter 2020
- Correction: NeuroRx and Relief announce initial successful results from expanded access use of RLF-100(TM) (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients
- MetrioPharm AG: COVID-19 Therapeutic Agent: MetrioPharm Prepares to Conduct a Phase II Clinical Trial
- EVOTEC AND RAPPTA THERAPEUTICS ENTER DISCOVERY AND DEVELOPMENT PARTNERSHIP FOCUSED ON ONCOLOGY TARGET
- Polyphor receives award of up to USD 3.3 million from Cystic Fibrosis Foundation to support clinical development of inhaled antibiotic murepavadin
- Chief Operating Officer Dr. Stefan Glombitza appointed to Formycon AG’s Management Board for another Four Years
- NeuroRx and Relief announce initial successful results from expanded access use of RLF-100(TM) (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients
- Pandion Therapeutics Appoints Katina Dorton to its Board of Directors
- BioAge Raises $90M to Treat Aging and Age-related Diseases
- PolyPid to Host Key Opinion Leader Call Discussing D-PLEX₁₀₀ and the Prevention of Surgical Site Infections
- FDA Clears Rezolute’s IND Application for RZ402
- Enlivex Reports Positive Interim Results From Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
- Progenity, Inc. Prices $75.0 Million Convertible Senior Notes Offering
- Progenity Announces Pricing of Public Offering of Common Stock
- Codexis Announces Pricing of Public Offering of Common Stock
- Kinnate Biopharma Announces Pricing of Initial Public Offering
- Blood Sugar Premier Market Research: Review On Zenith Labs Supplement Fix Irregular Sugar Levels?
- Codexis Announces Proposed Public Offering of Common Stock
- Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Stryker declares a $0.63 per share quarterly dividend
- Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent Developments
- Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Stryker declares a $0.63 per share quarterly dividend
- Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent Developments
- Arcutis to Host Virtual Investor Day on Wednesday, December 9, 2020
- SeaSpine Announces Limited Commercial Launch of its Admiral™ ACP System
- Valneva Announces Acceleration of Pediatric Development for Lyme Disease Vaccine Candidate
- Axiom will be Presenting and Exhibiting at Clinical Trials in Rare Diseases 2020: A Virtual Event
- Progressive Care Announces Confidential Submission of Draft Registration Statement
- RoosterBio Collaborates with Sartorius to Expand Cell and Gene Therapy Manufacturing Platform Technology into South Korea
- Torrey Smith Joins Rose Health as Investor and Brand Ambassador to Promote Mental Health Resilience
- Single-Dose Radiation Therapy At Time Of Lumpectomy Helps Breast Cancer Patients Overcome Treatment Challenges During Pandemic
- SteroTherapeutics, LLC signs CRADA Agreement with NIH to Develop a Novel Treatment for Cushing Syndrome Patients
- NeuBase Therapeutics Announces Appointment of Curt Bradshaw, Ph.D. as Chief Scientific Officer
- Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9
- Biosight Closes $46M Series C Financing to Advance Clinical Oncology Programs
- BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News